Atorvastatin: beyond lipid-lowering effects in the diabetic population.

Abstract

Statins are the mainstay of therapy in coronary artery disease and hypercholesterolemia. Atorvastatin is a 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor that is taken once daily. It has been shown to considerably reduce cardiovascular mortality events. Recently, several trials have demonstrated that atorvastatin has pleiotropic effects beyond its lipid-lowering capacities. Atorvastatin is especially beneficial in diabetics for stroke prevention and improving cardiovascular mortality risk.

• Authors: Julie Ramos, Qamar A Khan, Martin Thoenes, Bobby V Khan
• Journal: Future cardiology (Future Cardiol) Vol. 2 Issue 5 Pg. 527-33 (Sep 2006) ISSN: 1744-8298 [Electronic] England
• PMID: 19804188 (Publication Type: Journal Article)